Acetazolamide Capsule
Product Images NDC 65841-762

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 65841-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (53b2649b A1e7 4855 9021 30f825ff6bb6 01)

Figure (53b2649b A1e7 4855 9021 30f825ff6bb6 01)
Chemical structure of acetazolamide showing molecular configuration with atoms and functional groups labeled according to standard chemical notation.*
FDA Label Image

Figure (53b2649b A1e7 4855 9021 30f825ff6bb6 02)

Figure (53b2649b A1e7 4855 9021 30f825ff6bb6 02)
Label for Acetazolamide Extended-Release Capsules, USP 500 mg by Zydus Lifesciences Limited. The label states the product is a prescription oral capsule containing 500 mg of acetazolamide, with a package size of 100 capsules. It includes storage instructions, child-resistant packaging notice, and a barcode. The label also displays the NDC 65841-762-01 and the manufacturer's location in Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.